The role of endocytic pathways in cellular uptake of plasma non-transferrin iron

Haematologica

Volumn 97, Issue 5, 2012, Pages 670-678

  Sohn, Yang Sung ^a   Ghoti, Hussam ^b,c   Breuer, William ^a   Rachmilewitz, Eliezer ^b   Attar, Samah ^c   Weiss, Guenter ^d   Ioav Cabantchik, Z ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c The European Hospital   (Palestine)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Chelators; Fluorescence; Iron; Macrophages; Thalassemia

Indexed keywords

1 (5 CHLORO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; APOTRANSFERRIN; CALCEIN; CHELATING AGENT; CYTOCHALASIN D; FERRIC CITRATE; HETASTARCH; HUMAN SERUM ALBUMIN; IRON; NOCODAZOLE; NON TRANSFERRIN BOUND IRON; TRANSFERRIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENDOCYTOSIS; ENDOSOME; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART MUSCLE CELL; HUMAN; IRON BINDING CAPACITY; IRON TRANSPORT; MACROPHAGE; MOUSE; MYOBLAST; NONHUMAN; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CYTOSOL; ENDOCYTOSIS; ENDOSOMES; HUMANS; INSULINOMA; IRON; IRON CHELATING AGENTS; MACROPHAGES; MICROSCOPY, FLUORESCENCE; MYOCYTES, CARDIAC; TRANSFERRIN; YOUNG ADULT;

EID: 84860579118     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.054858     Document Type: Article

References (38)

1. Hershko C, Peto TE. Non-transferrin plasma iron. Br J Haematol. 1987;66(2):149-51.
2. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18(2):277-287.
3. Porter JB. Pathophysiology of iron overload. Hematol Oncol Clin North Am. 2005;19(Suppl 1):7-12.
4. Hider RC, Silva A, Podinovskaia M, Ma YM. Monitoring the efficiency of iron chelation therapy: the potential of nontransferrinbound iron. Ann NY Acad Sci. 2010;1202: 94-99.
5. Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfus Sci. 2000;23(3):185-192.
6. Ponka P. Rare causes of hereditary iron overload. Semin Hematol. 2002;39(4):249-262.
7. Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011;364(2):146-156.
8. Liu P, Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther. 1994;8(1):101-110.
9. Cabantchik ZI, Fibach E, Breuer W. Can labile plasma iron (LPI) and labile cell iron (LCI) levels serve as early indicators of chelation efficacy in iron overload? BloodMed.com. 2009. Available from: http://www.bloodmed.com/800000/minireviews1.asp?id=254
10. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrinbound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear resonance spectroscopy. J Biol Chem. 1989;264(8): 4417-44.
11. Hider RC. Nature of nontransferrin-bound iron. Eur J Clin Invest. 2002;32(Suppl 1):50-4.
12. Evans RW, Rafique R, Zarea A, Rapisarda C, Cammack R, Evans PJ, et al. Nature of nontransferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J Biol Inorg Chem. 2008;13(1):57-74.
13. Glickstein H, Ben El R, Shvartsman M, Cabantchik ZI. Intracellular labile iron pools as direct targets of iron chelators. A fluorescence study of chelator action in living cells. Blood. 2005;106(9):3242-50
14. Sohn YS, Breuer W, Munnich A, Cabantchik ZI. Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood. 2008;111(3):1690-9.
15. Nairz M, Fritsche G, Crouch ML, Barton HC, Fang FC, Weiss G, et al. Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition. Cell Microbiol. 2009;11(9):1365-81.
16. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA. 1998;95(6):2979-84.
17. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI, et al. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood. 2001;97(3):792-8.
18. Breuer W, Ghoti H, Shattat A, Goldfarb A, Koren A, Rachmilewitz E, et al. Non-transferrin bound iron in Thalassemia: differential detection of redox active forms in children and older patients. Am J Hematol. 2012;87(1):55-61.
19. Epsztejn S, Kakhlon O, Breuer W, Glickstein H, Cabantchik ZI. A fluorescence assay for the labile iron pool (LIP) of mammalian cells. Anal Biochem. 1997;248(1):31-40.
20. Espósito BP, Epsztejn S, Breuer W, Cabantchik ZI. A review of fluorescence methods for assessing labile iron in cells and biological fluids. Anal. Biochem. 2002; 304(1):1-18.
21. Ali A, Zhang Q, Dai J, Huang X. Calcein as a fluorescent iron chemosensor for the determination of low molecular weight iron in biological fluids. Biometals. 2003;16(2):285-293.
22. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann NY Acad Sci. 1998;850:191-201.
23. Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates nontransferrin-bound iron uptake into cells. Proc Natl Acad Sci USA. 2006;103(37):13612-13617.
24. Ludwiczek S, Theurl I, Muckenthaler MU, Jakab M, Mair SM, Theurl M, et al. Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med. 2007;13(4):448-454.
25. Oudit GY, Sun H, Trivieri MG, Koch SE, Dawood F, Ackerley C, et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med. 2003;9(9):1187-1194.
26. Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med. 2006;84(5):349-364.
27. Crowe S, Bartfay WJ. Amlodipine decreases iron uptake and oxygen free radical production in the heart of chronically iron overloaded mice. Biol Res Nurs. 2002;3(4):189-197.
28. Løvstad RA. Interactions of serum-albumin with the Fe(III)-citrate complex. Int JBiochem. 1993;25(7):1015-1017.
29. Silva AM, Hider RC. Influence of nonenzymatic post-translation modifications on the ability of human serum albumin to bind iron: implications for nontransferrin-bound iron speciation. Biochem Biophys Acta. 2009;1794(10):1449-5148.
30. Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood. 1996;88(9):3608-3614.
31. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol. 2006;135(2):254-263.
32. Kakhlon O, Gruenbaum Y, Cabantchik ZI. Repression of ferritin expression increases the labile iron pool, oxidative stress and shortterm growth of human erythroleukemia cells. Blood. 2001;97(9):2863-2871.
33. Kerr MC, Teasdale RD. Defining macropinocytosis.Traffic. 2009;10(4):364-371.
34. Soeiro Mde N, Mota RA, Batista Dda G, Meirelles Mde N. Endocytic pathway in mouse cardiac cells. Cell Struct Funct. 2002;27(6):469-478.
35. Swildens J, de Vries AA, Li Z, Umar S, Atsma DE, Schalij MJ, et al. Integrin stimulation favors uptake of macromolecules by cardiomyocytes in vitro. Cell Physiol Biochem. 2010;26(6):999-1010.
36. Cowan DB, Noria S, Stamm C, Garcia LM, Poutias DM, del Nido PJ, et al. Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes. Circ Res. 2001;88(5):491-498.
37. Pow DV, Morris JF. Membrane routing during exocytosis and endocytosis in neuroendocrine neurones and endocrine cells: use of colloidal gold particles and immunocytochemical discrimination of membrane compartments. Cell Tissue Res. 1991;264(2): 299-316.
38. Soe-Lin S, Apte SS, Andriopoulos B Jr, Andrews MC, Schranzhofer M, Kahawita T, et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc Natl Acad Sci USA. 2009;106(14):5960-5965.